8.1 Kopfschmerz induziert durch akuten Substanzgebrauch oder akute Substanzexposition

Altura BM, Altura BT, Gebrewold A.

Alcohol induced spasm of cerebral blood vessels. J Mental Sci 2000;104:972-999.

Armstrong, P.J. and A. Bersten (1986).

Normeperidine toxicity. Anesth Analg 65:536-538.

Ashina M, Bendtsen L, Jensen R, Olesen J.

Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000; 123: 1830-1837.

Bouillabaisse: an outbreak of methemoglobinemia in New Jersey in 1992.

Pediatrics 94:381-384.

Askmark H, Lundberg PO, Olsson S.

Drug related headache. Headache 1989; 29:441-444.Atkins, F.M. (1986). A critical evaluation of clinical trials in adverse reactions to foods in adults. J Allergy Clin Immunol 78:174-182.

Beck, H.G., W.H. Schulze, and G.M. Suter (1940).

Carbon monoxide-a domestic hazard. JAMA 115:1.

Bonnet, G.F. and P. Nepveux (1971).

Migraine due to tyramine. Sem Hop 47:2441-2445.

Brewerton, T.D., D.L. Murphy, M.D. Lesem, H.A. Brandt, and D.C. Jimerson (1992).

Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache 32:217-22.

Catalano, G., M.C. Catalano, and R. Rodriguez (1997).

Dystonia associated with crack cocaine use. South Med J 90:1050-1052.

Cleophas, T.J., M.G. Niemeyer, E.E. vanderWall, and J. vanderMeulen (1996).

Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dose. Angiology 47:679-685.

Council of Scientific Affairs (1985).

Aspartame: review of safety issues. JAMA 254:400-402.

Cregler, L.L. and H. Mark (1986).

Medical complications of cocaine abuse. N Engl J Med 315:1495-1501.

Dalton K (1976).

Migraine and oral contraceptives. Headache 15: 247-251.

Dhopesh, V., I. Maany, and C. Herring (1991).

The relationship of cocaine to headache in polysubstance abusers. Headache 31:17-19.

Dhuna, A., A. Pascual-Leone, and M. Belgrade.

Cocaine-related vascular headaches. J Neurol Neurosurg Psychiat 1991;54:803-6.

De Marinis M, Janiri L, Agnoli A.

Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 1991; 31: 159-163.

Ekbom, K. (1968).

Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 19:487-493.

el-Mallakh, R.S. (1987).

Marijuana and migraine. Headache 27:442-443.

el-Mallakh, R.S., H.R. Kranzler, and J.R. Kamanitz (1991).

Headaches and psychoactive substance use. Headache 31:584-587.

Forbes, H.S., S. Cobb, and F. Fremont-smith (1924).

Cerebral edema and headache following carbon monoxide asphyxia. Arch Neurol Psychiatr 11:164.

Gawin, F.H. (1991).

Cocaine addiction: psychology and neurophysiology. Science 251:1580-1586.

Ghose, K. and J.D. Carrol (1984).

Mechanisms of tyramine-induced migraine: similarities with dopamine and interactions with disulfiram and propranolol. Neuropsychiobiol 12:122-126.

Gordon, C.R., D. Mankuta, A. Shupak, O. Spitzer, and I. Doweck (1991).

Recurrent classic migraine attacks following transdermal scopolamine intoxication. Headache 31:172-174.

Gore ME, Salmon PR.

Chinese restaurant syndrome: fact or fiction. Lancet 1980;318:251-2.

Hanington, E. and A.M. Harper (1968).

The role of tyramine in the etiology of migraine and related studies on the cerebral and intracerebral circulations. Headache 8:84-97.

Hansen, H.J. and V.M. Drewes (1970).

The nitroglycerine ointment test-a double-blind examination. Dan Med Bull 17:226-229.

Heckerling, P.S., J.B. Leikin, A. Maturen, and J.T. Perkins (1987).

Predictors of occult carbon monoxide poisoning in patients with headache and dizziness. Ann Int Med 107:174-176.

Henderson, W.R. and N.H. Raskin (1972).

"Hot dog" headache: individual susceptibility to nitrite. Lancet 2:1162-1163.

Hirsch, A.R., K.M. Rankin, and P.P. Panelli (1996).

Trichloroethylene exposure and headache. Headache Quarterly 7:126-138.

Horowitz, L.D., M.V. Herman, and R. Gorlin (1972).

Clinical response to nitroglycerine as a diagnostic test for coronary artery disease. Am J Cardiol 29:149-153.

Iversen HK, Nielsen TM, Olesen J, Tfelt-Hansen P (1989).

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38: 17-24.

Kenney, R.A. and C.S. Tidball (1972).

Human susceptibility to oral monosodium 1-glutamate. Am J Clin Nutr 25:140-146.

Kerr, G.R., M.W. Lee, M. elLozy, R. McGandy, and F. Stare (1979).

Prevalence of the "Chinese restaurant syndrome". J Am Diet Assoc 75:29-33.

Krabbe, A.A. and J. Olesen (1980).

Headache provocation by continuous intravenous infusion of histamine, clinical results and receptor mechanisms. Pain 8:253-259.

Larkin, J.M., G.J. Brahos, and J.A. Moylin (1976).

Treatment of carbon monoxide poisoning: prognostic factors. J Trauma 16:111.

Lassen LH, Thomsen LL, Olesen J (1995).

Histamine induces migraine via the H receptor. Support for the NO-hypothesis of migraine. Neuroreport 6: 1475-1479.

Leon, A.S., D.B. Hunninghake, C. Bell, D.K. Rassin, and T.R. Tephly (1989).

Safety of long-term doses of aspartame. Arch Int Med 149:2318-2324.

Leone, M., A. Attanasio, D. Croci, G. Filippini, D. D'Amico, L. Grazzi, A. Nespolo, and G. Bussone (2000).

The serotonergic agent m-chlorophenylpiperazine induced migraine attacks: a controlled study. Neurology 55:136-139.

Levine, S.R., J.C. Brust, N. Futrell, and et al. (1990).

Cerebrovascular complications of the use of the crack form of alkaloidal cocaine. N Engl J Med 323:699-704.

Lipton, R.B., C.M. Kwong, and S. Solomon.

Headaches in hospitalized cocaine users. Headache 1989;29:225-8.

Lowenstein, D.H., S.M. Massa, M.C. Rowbotham, and et al. (1987).

Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83:841-846.

Luthy, J. and C. Schlatter (1983).

Biogenic amines in food: effects of histamine, tyramine and phenylethylamine in the human. Z Lebensm Unters Forsch 177:439-443.

Magos AL, E Brewster, R Singh T O?Dowd, M Brincat, JWW Studd (1986).

The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93: 1290-1296.

McCullock, J. and A.M. Harper (1978).

Phenylethylamine and the cerebral circulation. In Current concepts in migraine research, (J. McCullock and A.M. Harper, eds.) pp. 85-88. Raven Press, New York.

Meigs, J.L. and J.P. Hughes (1952).

Acute carbon monoxide poisoning: an analysis of 105 cases. AMA Arch Ind Hygiene Occupat Med 6:344-356.

Merkel, P.A., W.J. Koroshetz, M.C. Irizarry, and M.E. Cudkovicz (1995).

Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 25:172-183.

Merrit, J.E. and P.B. Williams (1990).

Vasospasm contributes to monosodium glutamate-induced headache. Headache 30:575-580.

Mitchell, J.D. (1995).

Clinical neurotoxicology: In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 1-22. Elsevier Science,

Moffet, A.M., M. Swash, and D.F. Scott (1974).

Effect of chocolate in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 37:445-448.

Monteiro, J.M. (1993).

Headache associated with single use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 715-720. Raven Press, Limited, New York.

Monteiro, J.M. and C.G. Dahlof (2000).

Single use of substances. In The Headaches, (J. Olesen, P. Tfelt-Hansen, and K.M. Welch, eds.) pp. 861-869. Lippincott Williams & Wilkins, Philadelphia.

Murphree, A.B., L.A. Greenberg, and R.B. Carrol (1967).

Neuropharmacologic effects of substances other than ethanol in alcoholic beverages. Fed Proc 26:1468-1473.

Nappi RE, A Cagnacci, F Granella, F Piccinini, F Polatti, F Facchinetti (2001).

Course of primary headaches during hormone replacement therapy. Maturitas 38: 157-63.

Norton, S. (1975).

Toxicology of the central nervous system. In Toxicology, (L.J. Casarett and J. Doult, eds.) pp. 1019-1035. MacMillan, New York.

Ogata S, Hosoi T, Saji H.

Studies on acute alcohol intoxication. Japanese Journal of Studies of Alcohol 1966; 1: 67-79.

Peters, G.A. (1953).

Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Mayo Clin 28:673-686.

Reif-Lehrer, L. (1977).

A questionnaire study of the prevalence of Chinese restaurant syndrome. Fed Proc 36:1617-1623.

Sabatini, U., O. Rascol, A. Rascol, and J.L. Montastruc (1990).

Migraine attacks induced by subcutaneous apomorphine in two migrainous Parkinson Ian patients. Clin Neuropharmacol 13:264-267.

Satel, S.L. and F.H. Gawin (1989).

Migraine-like headache and cocaine use. JAMA 261:2995-2996.

Schamburg, H.H., R. Byck, R. Gerstl, and J.H. Mashman (1969).

Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science 163:826-828.

Scher, W. and B.M. Scher (1992).

A possible role for nitric oxide in glutamate (MSG)-induced Chinese restaurant syndrome, glutamate induced asthma, "hot-dog headache", pugilistic Alzheimer?s disease, and other disorders. Med Hypotheses 38:185-188.

Schiffmann, S.S., C.E. Buckley, H.A. Sampson, and et al. (1987).

Aspartame and susceptibility to headache. N Engl J Med 317:1181-1185.

Schnitker, M.T. and M.A. Schnitker (1947).

Clinical notes, suggestions and new instruments. J Amer Med Assoc 135:89

Schwartz, A.M. (1946).

The cause, relief and prevention of headache arising from contact with dynamite. N Engl J Med 235:541-544.

Scopp, A.L. (1991).

MSG and hydrolyzed vegetable protein induced headache review and case studies. Headache 31:107-110.

Seltzer, S. (1982).

Foods and drug combinations, responsible for head and neck pain. Cephalalgia 2:111-124.

Shaw, S.W., R.H. Johnson, and H.G. Keogh (1978).

Oral tyramine in dietary migraine sufferers. In Current concepts in migraine research, (S.W. Shaw, R.H. Johnson, and H.G. Keogh, eds.) pp. 31-39. Raven Press, New York.

Shively, M. and B. Riegel (1991).

Effect of nitroglycerin ointment placement on headache and flushing in health subjects. Int J Nurs Stud 28:153-161.

Sicuteri, F., E.D. Bene, M. Poggioni, and A. Bonazzi (1987).

Unmasking latent dysnociception in healthy subjects. Headache 27:180-185.

Smith, I., A.H. Kellow, and E. Hanington (1970).

Clinical and biochemical correlation between tyramine and migraine headache. Headache 10:43-52.

Tarasoff, L. and M.F. Kelly (1993).

Monosodium L-glutamate: a double-blind study and review. Food Chem Toxicol 31:1019-1035.

Thomsen LL, Kruse C, Iversen HK, Olesen J.

A Nitric oxide donor triggers genuine migraine attacks. Eur J Neurol 1994; 1: 71-80.

Towers, C.V., R.A. Pircon, M.P. Nageotte, M. Porto, and T.J. Garite (1993).

Cocaine intoxication presenting as preeclampsia and eclampsia. Ob Gyn 81:545-547.

Trelles, L. and R. Jeri.

Central nervous system stimulants: cocaine, amphetamine, nicotine. In Handbook of clinical neurology, (F.A. DeWolff, ed.). New York: Elsevier Science, 1995: 251-7.

Wallgreen H, Barry A.

Drug actions in relation to alcohol effects. In: Action of alcohol. New York: Elsevier, 1970:621-714.

Wilson, J. (1995).

Cyanogenic glycosides. Ch. 3 in Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science, 1995: 25-34.

Varon J, Marik PE, Fromm RE, Gueler A.

Carbon Monoxide Poisoning: a review for clinicians. J. Emerg Med 1999; 17:87-93.

Yang, W.H., M.A. Drouin, M. Herbert, Y. Mao, and J. Kursh (1997).

The monosodium glutamate symptom complex: assessment in a double blind, placebo controlled, randomized study. J Allergy Clin Immunol 99:757-762.

8.2 Kopfschmerz bei Medikamentenübergebrauch

Ala-Hurula, V., V. Myllyla, and E. Hokkanen (1982).

Ergotamine abuse: results of ergotamine discontinuation with special reference to the plasma concentrations. Cephalalgia 2:189-195.

Ala-Hurula, V., V. Myllyla, E. Hokkanen, and O. Tokola (1981).

Tolfenamic acid and ergotamine abuse. Headache 21:240-242.

Allgulander, C. (1986).

History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatr Scand 73:465-478.

Andersson, P.G. (1975).

Ergotamine headache. Headache 15:118-121.

Baar, H.A. (1990).

Treatment for headache: a four-step standardized withdrawal program for analgesic abusers. Pain Clin 3:173-177. (Abstract).

Bennett, W.M. and M.E. DeBroe (1989).

Analgesic nephropathy: a preventable renal disease. N Eng J Med 320:1269-1271.

Bowdler, I., J. Killian, and S. Gänsslen-Blumberg.

The association between analgesic abuse and headache--coincidental or causal. Headache 1988;28:494.

Braithwaite RA.

The toxicity of tricyclic and newer antidepressants. In Handbook of Clinical Neurology, (F.A. DeWolff, ed.) pp. 311-320. New York: Elsevier Science 1995:311-20.

Brust, J.C. (1995).

Opiate addiction and toxicity. Ch. 16 in Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science: 356-361.

Catarci, T., F. Fiacco, and C. Argentino (1994).

Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 14:374-375.

Centonze, V., B.M. Polite, M. diBari, P. Caporaletti, and O. Albano (1993).

Vascular injuries in ergotamine abuse: a case report. Funct Neurol 8:265-270.

Dalquen, P., J. Fasel, M.J. Mihatsch, M. Rist, and G. Rutishauser (1980).

Phenacetinabusus IV. Sind zytologische harnuntersuchungen in der tumorvorsorge bei phenacetinabusern erfolgversprechend und anwendbar. Schweizerische Medizinische Wochenschrift 110:302-306.

DeBroe, M.E. and M.M. Elseviers (1993).

Analgesic nephropathy--still a problem? Nephron 64:505-513.

deMarinis, M., L. Janiri, and A. Agnoli (1991).

Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 31:159-163.

Diamond, S. and D.J. Dalessio (1982).

Drug abuse in headache. In The practicing physician's approach to headache, (S. Diamond and D.J. Dalessio, eds.) pp. 114-121. Williams & Wilkins, Baltimore.

Dichgans, J. and H.C. Diener (1988).

Clinical manifestations of excessive use of analgesic medication. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 8-15. Springer-Verlag, Berlin.

Dichgans, J., H.D. Diener, W.D. Gerber, and et al. (1984).

Analgetika-induzierter dauerkopfschmerz. Dtsch Med Wschr 109:369-73.

Diener, H.C. (1993).

A personal view of the classification and definition of drug dependence headache. Cephalalgia 13:68-71.

Diener, H.C. and C.G. Dahlof (1999).

Headache associated with chronic use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 871-878. Lippincott, Williams & Wilkins, Philadelphia.

Diener, H.C., J. Dichgans, E. Scholz, S. Geiselhart, W.D. Gerber, and A. Bille (1989).

Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236:9-14.

Diener, H.C., J. Haab, C. Peters, S. Ried, J. Dichgans, and A. Pilgrim (1991).

Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 31:205-209.

Diener, H.C., V. Pfaffenrath, D. Soyka, and W.D. Gerber (1992).

Therapie des medikamenten-induzierten dauerkopfschmerzes. Münch Med Wschr 134:159-162.

Diener, H.C. and P. Tfelt-Hansen (1993).

Headache associated with chronic use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 721-727. Raven press LTD, New York.

Dige-Petersen, H., N.A. Lassen, J. Noer, K.H. Toennesen, and J. Olesen (1977).

Subclinical ergotism. Lancet i:65-66.

Drucker, P. and S. Tepper (1998).

Daily sumatriptan for detoxification from rebound. Headache 38:687-690.

Dubach, U.C., B. Rosner, and E. Pfister (1983).

Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 308:357-362.

Elkind, A.H. (1989).

Drug abuse in headache patients. Clin J Pain 5:111-120.

Elkind, A.H. (1991).

Drug abuse and headache. Med Clin N Am 75:717-732.

Evers, S., I. Gralow, B. Bauer, B. Suhr, A. Buchheister, I.W. Husstedt, and E.B. Ringelstein (1999).

Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 22:201-206.

Fanciullaci, M., M. Alessandri, U. Pietrini, E. Briccolani-Bandini, and S. Beatrice (1992).

Long-term ergotamine abuse: effect on adrenergically induced mydriasis. Clin Pharm Ther 51:302-307.

Fincham, J.E. (1987).

Over-the-counter drug use and misuse by the ambulatory elderly: a review of the literature. J Ger Drug Ther;1:3-21.

Fincham, R.W., Z. Perdue, and V.D. Dunn (1985).

Bilateral focal cortical atrophy and chronic ergotamine abuse. Neurology 35:720-722.

Fisher, C.M. (1988).

Analgesic rebound headache refuted. Headache 28:666.

Friedman, A.P., P. Brazil, and T.J. vonStorch (1955).

Ergotamine tolerance in patients with migraine. JAMA 157:881-884.

Gaist, D., J. Hallas, S.H. Sindrup, and L.F. Gram (1996).

Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 50:161-165.

Gaist, D., I. Tsiropoulus, S.H. Sindrup, J. Hallas, B.K. Rasmussen, and J. Kragstrup (1998).

Inappropriate use of sumatriptan: population based register and interview study. Br J Med 316:1352-1353.

Granella, F., S. Farina, G. Malferrari, and G.C. Manzoni (1987).

Drug abuse in chronic headache: a clinicoepidemiologic study. Cephalalgia 7:15-19.

Gutzwiller, F. and E. Zemp (1986).

Der analgetikakonsum in der bevölkerung und socioökonomische aspekte des analgetikaabusus. In Das analgetikasyndrom, (M.J. Mihatsch, ed. ) pp. 197-205. Thieme, Stuttgart.

Hering, R. and T.J. Steiner (1991).

Abrupt outpatient withdrawal from medication in analgesic-abusing migraineurs. Lancet 337:1442-1443.

Hokkanen, E., O. Waltimo, and T. Kallanranta (1978).

Toxic effects of ergotamine used for migraine. Headache 18:95-98.

Horowski, R. and A. Ziegler (1988).

Possible pharmacological mechanisms of chronic abuse of analgesics and other antimigraine drugs. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds. ) pp. 95-104. Springer-Verlag, Berlin.

Horton, B.T. and G.A. Peters (1963).

Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3:214-226.

Isler, H. (1982).

Migraine treatment as a cause of chronic migraine. In Advances in migraine research and therapy, (F.C. Rose, ed.) pp. 159-164. Raven Press, New York.

Jaffe, J.H. (1985).

Drug addiction and drug abuse. In The pharmacological basis of therapeutics, (A.G. Gilman, T.W. Rall, A.S. Nies, and P. Taylor, eds. ) pp. 522-573. Pergamon Press, New York.

Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V.

Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57:1694-1698.

Kaube, H., A. May, H.C. Diener, and V. Pfaffenrath (1994).

Sumatriptan misuse in daily chronic headache. Br Med J 308:1573.

Kielholz, P. and D. Ladewig (1981).

Probleme des medikamentenmi beta-brauches. Schweiz Ärztezeitung 62:2866-2869.

Klapper, J.A. (1992).

Rebound headache: definition, symptomatology, treatment, and prevention. Headache Quarterly 3:398-402.

Kouyanou, K., C.E. Pither, S. Rabe-Hesketh, and S. Wessely (1998).

A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explained symptoms. Pain 76:417-426.

Kudrow, L. (1982).

Paradoxical effects of frequent analgesic use. Adv Neurol 33:335-341.

Lader M.

Hypnotics and sedatives. In Handbook of clinical neurology, (F.A. DeWolff, ed.). New York: Elsevier Science 1995: 329-55.

Lance, F., C. Parkes, and M. Wilkinson (1988).

Does analgesic abuse cause headache de novo? Headache 61-62.

Lance, J.W. (1990).

A concept of migraine and the search for the ideal headache drug. Headache 30:17-23.

Limmroth, V., S. Kazarawa, G. Fritsche, and H.C. Diener (1999).

Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 353:378.

Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC.

Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-1014.

Lucas, R.N. and W. Falkowski (1973).

Ergotamine and methysergide abuse in patients with migraine. Br J Psychiatry 122:199-203.

Ludolph, A.C., I.W. Husstedt, H.P. Schlake, K.H. Grotemeyer, and G.G. Brune (1988).

Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts. Eur Neurol 28:311-316.

MacGregor, E.A., C. Vorah, and M. Wilkinson (1990).

Analgesic use: a study of treatments used by patients for migraine prior to attending the City of London migraine clinic. Headache 30:634-638.

Manzoni, G.C., G. Micieli, F. Granella, G. Sandrini, C. Zanferrari, and G. Nappi (1988).

Therapeutic approach to drug abuse in headache patients. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 143-149. Springer-Verlag, Berlin.

Marks, V. (1981).

Reactive (rebound) hypoglycemia). In Hypoglycemia, (V. Marks and C.F. Rose, eds.) pp. 179-217. Blackwell, Oxford.

Mathew, N.T. (1987).

Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 27:130-133.

Mathew, N.T., R. Kurman, and F. Perez (1990).

Drug induced refractory headache - clinical features and management. Headache 30:634-638.

Michultka, D.M., E.B. Blanchard, K.A. Appelbaum, J. Jaccard, and M.P. Dentinger (1989).

The refractory headache patient--2. High medication consumption (analgesic rebound) headache. Behav Res Ther 27:411-420.

Micieli, G., G.C. Manzoni, F. Granella, E. Martignoni, G. Malferrari, and G. Nappi (1988).

Clinical and epidemiological observations on drug abuse in headache patients. In Drug-Induced Headache, (H.C. Diener and M. Wilkinson, eds.) pp. 20-28. Springer-Verlag, Berlin.

Nicolodi, M., P.L. DelBianco, and F. Sicuteri (1997).

The way to serotonergic use and abuse in migraine. Int J Clin Pharmacol Res 17:79-84.

Page, H. (1981).

Rebound headache from ergotamine withdrawal. JAMA 246:719.

Peters, G. and B.T. Horton (1951).

Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Mayo Clin 26:153-161.

Pini, L.A. and T. Trenti (1994).

Case report: does chronic use of sumatriptan induce dependence? Headache 34:600-601.

Pradalier, A., S. Dry, and J.F. Baron (1984).

Cephalée induite par l'abuse de tartrate d'ergotamine chez les migrainieux. Concours Méd 106:106-110.

Rahman, A., M. Segasothy, S.A. Samad, A. Zulfiqar, and M. Rani (1993).

Analgesic use and chronic renal disease in patients with headache. Headache 33:442-445.

Rapoport, A., P. Stang, D.L. Gutterman, R. Cady, H. Markley, R. Weeks, J. Saiers, and A.W. Fox (1996).

Analgesic rebound headache in clinical practice: data from a physician survey. Headache 36:14-19.

Rapoport, A.M. (1988a).

Analgesic rebound headache. Headache 28:662-665.

Rapoport, A.M. and R.E. Weeks (1988b).

Characteristics and treatment of analgesic rebound headache. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 162-167. Springer-Verlag, Berlin.

Roswell, A.R., C. Neylan, and M. Wilkinson (1973).

Ergotamine induced headache in migrainous patients. Headache 13:65-67.

Sandler, D.P., J.C. Smith, C.R. Weinberg, V.M. Buckalew, V.W. Dennis, W.B. Blythe, and W.P. Burgess (1989).

Analgesic use and chronic renal disease. N Engl J Med 320:1238-1243.

Saper, J.R. (1983a).

Drug abuse among headache patients. In Headache disorders, (J.R. Saper, ed.) pp. 263-278. PSG Publishers, Boston.

Saper, J.R. (1983b).

Drug overuse among patients with headache. Neurol Clin 1:465-477.

Saper, J.R. (1990).

Daily chronic headaches. Neurol Clin N Amer 8:891-902.

Saper, J.R. and J.M. Jones (1986).

Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 9:244-256.

Schnider, P., S. Aull, C. Baumgartner, and et al. (1996).

Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year followup. Cephalalgia 16:481-485.

Schnider, P., S. Aull, and M. Feucht (1994).

Use and abuse of analgesics in tension-type headache. Cephalalgia 14:162-167.

Schnider, P., J. Maly, J. Grunberger, S. Aull, K. Zeiler, and P. Wessely (1995).

Improvement of decreased critical flicker frequency in headache patients with drug abuse after successful withdrawal. Headache 35:269-272.

Schoenen, J., P. Lenarduzzi, and J. Sianard-Gainko (1989).

Chronic headaches associated with analgesics and/or ergotamine abuse: a clinical survey of 434 consecutive outpatients. In New advances in headache research, (F.D. Rose, ed.) pp. 29-43. Smith-Gordon, London.

Seller, E.M., U.E. Busto, H.L. Kaplan, G. Somer, and G.J. Baylon (1998).

Comparative abuse liability of codeine and naratriptan. Clin Pharmacol Ther 63:121.

Shakir, R.A. (1995).

Vitamin toxicity. In Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science: 567-576.

Silberstein, S.D. and R.B. Lipton (1997).

Chronic daily headache. In Headache, (P.J. Goadsby and S.D. Silberstein, eds.) pp. 201-225. Butterworth-Heinemann, Newton.

Silberstein, S.D., R.B. Lipton, S. Solomon, and N.T. Mathew (1994).

Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 34:1-7.

Silberstein, S.D. and J.R. Silberstein (1992).

Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE. Headache 32:439-445.

Stewart, J.H. (1978).

Analgesic abuse and renal failure in Australia. Kidney Internat'l 13:72-78.

Sullivan, J.T. and E.M. Sellers (1986).

Treatment of the barbiturate abstinence syndrome. Med J Aust 145:456-458.

Taschner, K.L. and G.A. Wiesbeck (1988).

Psychiatric aspects of drug addiction of the barbiturate-alcohol type. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 80-84. Berlin, Springer-Verlag.

Tfelt-Hansen, P. (1985).

Ergotamine headache. In Updating in headache, (V. Pfaffenrath, P. Lundberg, and O. Sjaastad, eds.) pp. 169-172. Springer, Berlin.

Tfelt-Hansen, P. (1986).

The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol 59:1-29.

Tfelt-Hansen, P. and A.A. Krabbe (1981a).

Ergotamine. Do patients benefit from withdrawal? Cephalalgia 1:29-32.

Tfelt-Hansen, P. and J. Olesen (1981b).

Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Acta Physiol Scand 48:69-72.

Tfelt-Hansen, P. and L. Paalzow (1985).

Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther 37:29-35.

Tfelt-Hansen, P., P.R. Saxena, and M.D. Ferrari (1995).

Ergot alkaloids. In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 61-67. New York: Elsevier Science.

Timmings, P.L. and A. Richens (1995).

Neurotoxicology of antiepileptic drugs. In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 495-513. New York: Elsevier Science.

Vasconcellos, E., J.E. Pina-Garza, E.J. Millan, and J.S. Warner (1998).

Analgesic rebound headache in children and adolescents. J Child Neurol 13:443-447.

Verhoeff, N.P., W.H. Visser, M.D. Ferrari, P.R. Saxena, and E.A. vonRoyen (1993).

Dopamine D2 receptor imaging with 123-I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier. Cephalalgia 13:325-329.

VonKorff, M., B.S. Galer, and P. Stang (1995).

Chronic use of symptomatic headache medications. Pain 62:179-186.

Walker, J., S. Parisi, and D. Olive (1993).

Analgesic rebound headache: experience in a community hospital. Southern Med J 86:1202-1205.

Warner, J.S. (1999).

Rebound headaches: a review. Headache Quarterly 10:207-219.

Zed, P.J., P.S. Loewen, and G. Robinson (1999).

Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 33:61-72.

Ziegler, D.K. (2000).

Opiate and opioid use in patients with refractory headache. Cephalalgia 14:5-10.

8.3 Kopfschmerz als Nebenwirkung zurückzuführen auf eine Dauermedikation

de Lignières B, Silberstein SD.

Pharmacodynamics of oestrogens and progestagens. Cephalalgia 2000;20:200-207.

Silberstein SD.

Hormone-related headache. M Clin N Am 2001;85:1017-1035.

Silberstein SD, de Lignières B.

Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000;20:214-212.

8.4 Kopfschmerz zurückzuführen auf den Entzug einer Substanz

Abbott, P.J. (1986).

Caffeine: a toxicological overview. Med J Aust 145:518-521.

Baumgartner, G.R. and R.C. Rowen (1991).

Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 84:312-321.

Dalessio, D.J. (1980).

Wolff's headache and other head pain, Oxford University Press, Oxford.

Epstein MT, JM Hockaday, TDR Hockaday (1975)

Migraine and reproductive hormones through the menstrual cycle. Lancet i:543-548.

Greden, J.F., M. Fontaine, M. Lubetsky, and K. Chamberlin (1978).

Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatr 135:963-966.

Laska, E.M., A. Sunshine, F. Mueller, W.B. Elvers, C. Siegel, and A. Rubin (1984).

Caffeine as an analgesic adjuvant. JAMA 251:1711-1718.

Lichten E, J Lichten, A Whitty, D Pieper (1996).

The confirmation of a biochemical marker for women?s hormonal migraine : the depo-oestradiol challenge test. Headache 36: 367-71.

Raskin, N.H. and O. Appenzeller (1980).

Headache, Saunders, Philadelphia.

Silverman, K., S.M. Evans, E.C. Strain, and R.R. Griffiths (1992).

Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Eng J Med 327:1109-1114.

Somerville B (1975).

Estrogen withdrawal migraine. Neurology 25: 239-250.

vanDusseldorp, M. and M.B. Katan (1990).

Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 300:1558-1559.

White, B.C., C.A. Lincoln, N.W. Pearcz, R. Reeb, and C. Vaida (1980).

Anxiety and muscle tension as consequence of caffeine withdrawal. Science 209:1547-1548.